restore you  omaha wellness clinic  denise pollard  omaha botox  aesthetic services close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  now located in our new office at lakeside new location  gold plaza • omaha nebraska  by denise pollard msn aprn bc advanced aesthetic services  bioidentical hormone replacement therapy about denisedenise pollard msn aprn bc is a board certified women’s health nurse practitioner men’s healthtestosterone therapy weight management womens health  beauty estrogen  testosterone therapy migraine management weight management aestheticsbotox juvederm voluma xc belafill ipl collagen induction therapy venus machinevenus freeze ipl laser hair removal sexual dysfunctionsexual enhancements our products omaha womens health  bioidentical hormone replacement therapy  migraine management  hcg diet close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  women’s health bioidentical hormone replacement therapy for women the signs and effects of the menopause transition can begin as early as age  although most women become aware of the transition in their mid to late s normally lasting for several years its duration varies for every woman and its course is impossible to predict there are many symptoms that women who are going through menopause and perimenopause experience however every woman’s experience is different and most women may not experience every symptom some of the most common symptoms involved in hormone imbalance in women include hot flashes nightsweats irritabilitymood swings weight gain vaginal dryness and loss of libido because there is a large number of symptoms women experience it is usually best to bring each of your symptoms up to your physician to be reviewed and discussed an individualized treatment plan can be reviewed with you to decrease symptoms and improve your overall health by lessening the incidence of chronic conditions that may occur with aging bioidentical hormone pellet therapy for women bioidentical hormone replacement therapy using the pellet method has changed the manner women age today we know that we don’t have to accept hormonal imbalance as a grim reality natural hormone replacement therapy has helped improve not only the quality of our lives but also how long we live them some doctors continue to say that women should stop whining and embrace our menopausal woes but why should we when the remedy is as simple as replacing missing hormones by “bioidentical” we mean that the biochemical structure of the hormone is perfectly matched to the hormone produced in a woman’s body by her endocrine system biodentical hormones are plantbased natural substances that our bodies can metabolize in the way it was designed to do thus minimizing side effects these compounded bioidenticals can be matched to each woman’s unique needs something that’s impossible with massmanufactured products migraine management a migraine headache can cause intense throbbing or a pulsing sensation in one area of the head and is commonly accompanied by nausea vomiting and extreme sensitivity to light and sound migraine attacks can cause significant pain for hours to days and be so severe that all you can think about is finding a dark quiet place to lie down activities of daily living can be significantly affected by migraine patterns most migraines in women are triggered by a hormonal imbalance when hormones are optimalized women notice improvements in their migraine patterns such as less frequent migraines or complete resolution of migraines we work collaboratively with local neurologists to provide the best management of migraines available hcg diet so what exactly can the hcg shots do for you the hcg shots will enable you to go on a calorie deficit without having the feeling of starvation often when a person is under a caloric deficit – especially in large numbers such as  and above the person will tend to feel weak and always hungry which often results into binge eating with these you can eat less and be on a caloric deficit without having to worry about starving the hcg diet helps in metabolizing the unwanted fat in your body in other words it burns fat and enables you to maintain the muscle in your body the hcg shots are enough to make you survive a  calorie diet without having to break down the common misconception with the hcg diet is that it is strictly for women that is simply not the case because even men can greatly benefit from this diet don’t be deceived by the origins of the hcg – it is for anyone who needs and wants to lose weight lipob injections lipob injection ensures your body receives all necessary nutrients to keep you at your energetic best many of these nutrients are not absorbable by mouth and need to be taken by injection injections are safe effective and an easy way to keep your body wellbalanced vitamin b lipotropic injections help increase your energy as well as contribute to the success of your weight loss plan schedule an appointment today restore you packages  venus freeze  fresh face  omaha ne close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  packages venus freeze “mommy makeover” alternative  treatments for only  a savings of  tired of working hard at the gym to flatten your tummy yet not seeing the results you’re looking for after childbirth women often find it difficult to regain the midsection they once had regardless of the effort they make to eat right and exercise regularly with our venus freeze we are able to assist you in a noninvasive painfree series of treatments that allow you to maintain your active lifestyle how it works using patented mp² technology venus freeze utilizes multipolar radio frequency and pulsed magnetic fields which produce a soothing and therapeutic heat matrix over the skin skin tightening wrinkle reduction and cellulite reduction occur because the multipolar radio frequency causes a thermal reaction in the tissue which stimulates the body’s natural healing response this restoring response causes new collagen to form and the production of new elastin fibres the active collage in the skin contracts achieving tighter skin softening of wrinkles and reduced cellulite individually these treatments are  per session but you can take advantage of our package discount and start seeing the results you’re looking for treatment is limited to abdominal area only per session with best results achieved after eight sessions restore you “fresh face” package this one hour session is guaranteed to refresh your look for only  a savings of  as we age it’s inevitable that our face will show wrinkles frown lines and loose volume in areas that can make us look older than we are or prevent us from looking our best in our “fresh face” package we address the various types of facial aging by combining our premium services into one great session at a tremendous savings from our retail pricing  units of botox  value  syringes of juvéderm voluma® xc  value  syringes of juvéderm® xc  value  venus freeze neckface treatment  value total retail value  plus one friend package only   each this package allows you and a friend to save together by booking backtoback appointments in one day get the “ready for the season” look you want while enjoying the day out with one of the girls or your spouse save  total… each  units of botox  each  value  syringes of juvederm  units each  value  ml fl oz size skin firming cream from glo therapeutics to take home  value  venus freeze neckface treatments  value total retail value  appointments must be scheduled backtoback no exceptions allow  minutes per person products  restore you  omahas wellness clinic close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  products evolution man eye gela powerful lightweight hydrator that addresses the three major issues of the under eye area puffiness dark circles and fine lines glo oil control emulsionbalances combination skin with a lightweight blend of humectants antibacterial agents and antioxidants evolution man wash  buffan efficient daily exfoliator powered by nonirritating microbeads helps to prevents black heads minimize pores and ingrown hairs glo skin firming cream skin looks luminous hydratedand firmer attracts water and does not let it escape recommended for mature dry and excessively dry skin restore you  contact  denise pollard close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  reservation  gold plaza  omaha ne  call  to schedule a personal consultation or treatment with denise please complete the form below and she will contact you when she’s finished with today’s patients as always we value our clients and look forward to speaking with you to see how we can assist you with your individual needs book now sexual dysfunction  restore you  omahas wellness clinic close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  sexual dysfunction what is sexual dysfunction female sexual dysfunction is not a small problem  of women experience some degree of low libido and dysfunction female sexual arousal disorder occurs in  of women which may not sound like a lot but when you think about it that is  in  women who suffer from sexual arousal disorder may want to have sex but have much difficulty finding the pleasure of arousal hypoactive sexual desire disorder or low desire is another type of sexual dysfunction experienced by women approximately  of women suffer with this problem another sexual disorder women may experience is female orgasmic disorder this is when a woman can become sexually aroused but has great difficulty achieving or cannot achieve an orgasm low desire occurs in approximately  of the female population lastly dyspareunia is a condition where the woman experiences real pain with intercourse the incidence of dyspareunia is from  in  to  in  women the previous statistics were from the journal of obstetrics  gynecology april  during my practice i have encountered numerous women with the above complaints and have been able to improve and even eliminate their symptoms suffering with a sexual disorder disorder does not simply make sex unenjoyable it can lead to stress on their relationships and decrease in self confidence as well as symptoms of depression improving a women’s sexual life can lead to increased energy more confidence less depression and improved overall health although each woman’s experience may differ in some ways many patients report greater arousal from clitoral stimulation younger smoother skin of the vulva lips of the vagina a tighter introitus vaginal opening stronger orgasm more frequent orgasm increased ability to have a vaginal orgasm decreased pain for those with dyspareunia painful intercourse increased natural lubrication decreased or resolved urinary incontinence both urge and stress problems after the procedure there’s no recovery time needed you may experience minimal side effects the most common side effect following injection includes scant bleeding from the needle injection site within  hours following the in office procedure you may resume normal sexual activity note that results vary venus freeze  restore you  omahas wellness clinic close please note that your appointment is not confirmed until you receive a phone call from restore you select a service skin fillers botox juve’derm and voluma xc fillers weight management sex drive restoration o shot p shot testosterone and estrogen sex drive hormone laser hair removal ipl venus freeze voluma xc highlights juve’derm highlights botox highlights migraine management skin tightening and cellulite reduction estrogen p shot sexual performance testosterone therapy express manicure deluxe pedicure deluxe manicure mineral mud wrap stress relief wrap clarifying back facial microdermabrasion signature restorative botanicals therapeutic swedish reflexology prenatal muscle melt hot stone number of guests is required date  time is required name is required email is required enter a valid email phone is required thank you for contacting us call us today  venus freeze what is venus freeze™ the venus freeze is a revolutionary treatment which is highly effective in circumference reduction improving cellulite skin tightening and reducing the appearance of wrinkles venus freeze uses pulsed magnetic fields which provide you with the added benefits of increased oxygen nutrients and blood to the skin – giving it an immediate and long lasting glow our promise is to provide you with a safe pleasant and painfree experience in treatments for the face and body including arms abdomen thighs buttocks neck and face how it works using patented mp² technology venus freeze utilizes multipolar radio frequency and pulsed magnetic fields which produce a soothing and therapeutic heat matrix over the skin skin tightening wrinkle reduction and cellulite reduction occur because the multipolar radio frequency causes a thermal reaction in the tissue which stimulates the body’s natural healing response this restoring response causes new collagen to form and the production of new elastin fibres the active collage in the skin contracts achieving tighter skin softening of wrinkles and reduced cellulite what to expect venus freeze treatments are noninvasive and painless with many patients comparing the treatment to a hotstone massage treatments take approximately mins depending on the area you can expect to see results as the treatments progress a minimum of  treatments for the face  on the neck and  on the body denise pollardknight  phase ventures limited  zoominfocom mereo biopharma announces formal launch of company raises 9m c£m and acquires innovative mereo biopharma announces formal launch of company raises 9m c£m and acquires innovative midstage clinical product portfolio from leading pharmaceutical company jul 9   et from mereo biopharma group ltd london july 9  prnewswire  a new uk company focused on acquiring rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health  highly experienced management team blue chip investors    mereo biopharma group ltd mereo a recentlyformed speciality biopharmaceutical company announces that it has successfully raised 9m c £m gross from blue chip institutional investors and simultaneously acquired a portfolio of three innovative clinicalstage development programmes from novartis pharmaceuticals novartis through the shares issued in consideration for the acquisition of products will also hold an equity stake in mereo   mereo is a new ukbased company whose mission is to acquire and rapidly develop innovative medicines that have the potential to transform patient quality of life and improve human health mereo intends to optimise the commercial value of programmes by entering into partnering deals at key value inflection points or for selected opportunities commercialising products itself mereo is building a strong pipeline of innovative medicines particularly focused in rare and specialist disease areas through the acquisition of validated midstage development programmes from large biopharmaceutical companies  mereo has access to an extensive network of experts with experience across multiple clinical disciplines and has entered into a strategic development partnership with icon a leading global contract research organisation cro for the clinical development of its portfolio   key investment highlights for mereo are as follows an innovative product portfolio from novartis  mereos initial midstage portfolio comprises three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need acquired from novartis each programme has a comprehensive dataset including proof of concept clinical studies mereos pipeline comprises the following programmes   bps in the orphan disease osteogenesis imperfecta or brittle bone syndrome is a fully human monoclonal antibody which is being developed to improve bone density and thereby reduce fractures in osteogenesis imperfecta oi commonly known as brittle bone syndrome bct9 in acute exacerbations of copd is an orally active p map kinase inhibitor being developed as firstline acute therapy alongside existing treatment and supportive care for acute exacerbations of chronic obstructive pulmonary disease aecopd   bgs9 in hypogonadotrophic hypogonadism is a novel orally active aromatase inhibitor being developed as a firstline therapy for the treatment of obese men with hypogonadotrophic hypogonadism hh with the aim of normalising testosterone levels   strategic development partnership with icon  mereos strategic partnership with icon provides a dedicated global team working closely with mereo from preacquisition through to conduct of global clinical studies for its pipeline products the relationship has been structured to enable mereo to expand its product portfolio without the addition of significant internal resources   a strong investor base  mereo has secured 9m c £m gross from uk institutional investors woodford investment management and invesco perpetual in addition novartis through the shares issued in consideration for the acquisition of products will hold an equity stake in mereo and intends to make a cash investment in mereo in future financings   a highly experienced management team  the team is led by dr denise scotsknight pollardknight as chief executive officer formerly managing partner of the healthcarefocused venture capital investor phase partners and dr peter fellner as chairman who has a wide range of experience in biotechnology and pharma companies mereos management team is highly experienced in identifying and selecting new product opportunities managing clinical development pipelines capital raising and structuring in and outlicensing transactions commenting on todays announcement dr denise scotsknight ceo of mereo said   we believe that by acquiring quality assets from novartis and securing substantial financing we have put in place the building blocks to create a successful specialty biopharmaceutical company through the experience and connections of the team and board we are delighted to have been able to work with a visionary global leader in novartis pharmaceuticals in building a new model to help optimise the development of pharmaceutical pipelines we believe the exceptional experience and track record of the mereo team and board will enable us to rapidly build a globally competitive business     commenting on todays announcement dr peter fellner chairman of mereo said we believe the substantial fundraising underpinning the launch of mereo is a strong endorsement from the investment community of our vision to create a ukbased biopharmaceutical leader this reflects both the extensive experience of the management team and board as well as the extremely high quality of programmes acquired from novartis which form the initial portfolio of mereo     wg partners llp acted as advisor to mereo biopharma in connection with this transaction proskauer teams in london and new york provided legal advice to mereo biopharma in relation to the transaction   about mereo  mereo is based in london and was founded in march  to fund and develop novel innovative specialist focused products from large pharmaceutical or biotechnology companies   pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs  with significant pl constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates especially beyond phase  mereo has been formed to take advantage of the global pharmaceutical industrys drive for creative ways to progress their clinical development pipelines   mereo has acquired an initial midlate stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from novartis pharmaceuticals each of these programmes has a comprehensive dataset for both preclinical and proofofconcept clinical studies  additional product opportunities are under evaluation mereos focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world  to do this the company depends on the combination of its teams expertise in selecting and acquiring product opportunities creating value in the development pipeline and structuring creative transactions mereos internal expertise is complemented by a unique partnership with a leading global cro icon mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies  mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products  the company also has the option to directly commercialise products for example in orphan disease indications   senior management and board of directors  management team  dr denise scotsknight ceo and cofounder   denise is our ceo a board member and cofounder of mereo prior to mereo she led phase partners mbo from nomura in  becoming phases managing partner prior to becoming a venture capitalist she was in rd management at amersham and fisons and a senior executive at scientific generics  at nomura she became managing director after heading the life science investment team  prior to nomura she was investment manager at rothschild asset management she is chairman of nabriva and board member of oncomed omed and albireo she has served on many european and us private and public boards including idenix until acquired by merck for bn denise has a phd and bsc hons from birmingham university and was fulbright scholar at uc berkeley richard bungay cfocoo   richard is our cfo and chief operating officer with responsibility for finance manufacturing and nonclinical development activities he has over  years experience in senior finance and strategic roles within the pharmaceutical and biotechnology sector latterly as cfo of glide technologies richards prior experience includes cfo of verona pharma ceo of chroma therapeutics director of corporate communications at celltech and finance director of the respiratory and inflammation therapy area at astrazeneca he qualified as a chartered accountant with deloitte and has a bsc in chemistry from nottingham university richard is a nonexecutive director of glide technologies and chroma therapeutics   charles sermon gc and cofounder   charles is our general counsel company secretary and a cofounder of mereo  he has over  years experience in corporate law prior to mereo he worked for phase partners since  he was also involved in phases mbo and the sale of nomuras life science portfolio in  he joined nomura as an associate director in 99 and worked for nomuras life science investment team before joining nomura charles was a corporate lawyer with freshfields charles has an llb hons from hull university and is a member of the mayor of london enterprise panels digital science and technology working group  charles is a board member of phase partners dr alastair mackinnon cmo and cofounder   alastair is our chief medical officer and a cofounder of mereo prior to mereo he worked for phase partners a global lifescience venture capital firm having originally joined nomura in  before nomura he was a practising physician in the uk for  years  alastair received a bsc and mbbs from kings college london is a member of the royal college of surgeons of edinburgh mrcs and has a diploma in corporate finance from the london business school alastair is a board member of phase partners   john richard head of corporate development and cofounder   john is our head of corporate development and a cofounder of mereo prior to mereo he worked with the cofounders at nomura then phase partners since  he has significant corporate operational and transactional experience having served in various executive director and advisory roles throughout his career he is a board member of biota phase partners que oncology and serves as chairman of targacept he is a corporate development advisor to albireo previously he was executive vp business development at sequus where he was responsible for negotiating sequus acquisition by alza  john also headed business development for vivus and genome therapeutics where he established numerous alliances he was also ceo and cofounder of impath subsequently acquired by genzyme john holds a mba from harvard business school and bs from stanford university board of directors  dr peter fellner chairman   in addition to mereo peter also serves as chairman of the biotech and medtech companies ablynxnv vernalis plc and consort medical plc  he was also chairman of optos until its recent acquisition by nikon corporation in addition he is a member of the novo as advisory group and a member of the ucb sa science advisory board he has previously served on the boards of a wide range of life science companies including as vicechairman of astex pharmaceuticals inc until its sale to otsuka in  director of the global biopharmaceutical company ucb sa from  to  and chairman of acambis plc from  until its acquisition by sanofi in  he was chairman of celltech group plc until its acquisition by ucb in  having been ceo from 9 before celltech he was ceo of roche uk from 9 to 9   dr denise scotsknight ceo  dr anders ekblom board director  anders has extensive experience as an executive and leader with broad business knowledge from senior roles in the biopharmaceutical industry with global working crossfunctions and different countries delivering products projects productivity and change management he is currently chairman of the board at karolinska university hospital and a nonexecutive board member of several biotech companies during two decades at astrazeneca he was a member of global executive teams including executive vp global drug development evp global medicines development global head clinical development global therapy area head global head science  technology integration and ceo astrazeneca ab sweden anders is also a board certified md anaesthesiology and intensive care phd dds and associate professor at karolinska institutet stockholm sweden and a fellow of the royal swedish academy of engineering sciences   dr frank armstrong board director  frank has served as ceo to a number of healthcare and biopharmaceutical companies including curagen and fulcrum pharma he held senior management positions including executive vp product development at bayer ag senior vp medical research at zeneca pharmaceuticals now astrazeneca and senior vp at merck serono frank holds a mbchb from the university of edinburgh and became a member of the royal college of physicians in 9 he was elected fellow of royal college of physicians edinburgh in 99 and also fellow of faculty of pharmaceutical physicians in 99   peter bains board director  peter has over two decades of experience in the pharmaceutical industry encompassing strategic and operational leadership expertise across global geographies functions and business segments he is currently ceo of syngene international a subsidiary of biocon asias largest biotechnology company he also currently serves as nonexecutive director for sosei a tokyo listed biotech company phase partners and kromek group a uk aim listed imaging and detection technology company he is also chairman of fermenta biotech a subsidiary of dil a mumbai listed company previously he had year career at glaxosmithkline where he held multiple senior roles peter received a bsc combined hons in physiologyzoology from sheffield university   kunal kashyap board director  kunal is a chartered accountant and is currently chairman and managing director of allegro capital advisors a leading indian investment bank  kunal has a deep understanding of the life sciences industry built over two decades of advising companies in the industry on fund raising ipos mergers and acquisitions ip licensing etc he is an independent director of glaxosmithkline consumer healthcare ltd and phase partners he was also founder and executive director of celstream technologies a leading software product engineering organization from 99 he was a global partner at arthur andersen responsible for building and developing the firms practice in southern india   pipeline summary  bct9 bps bgs9 development status a b b orphan bone therapeutic area respiratory disease metabolic indication aecopd oi hh monoclonal modality small molecule antibody small molecule mechanism of aromatase action p mapk inhibitor undisclosed inhibition mapk mitogenactivated protein kinase aecopd acute exacerbations of chronic obstructive pulmonary disease oi osteogenesisimperfecta hh hypogonadotrophic hypogonadism about osteogenesis imperfecta oi  oi is an orphan genetic disorder that is characterized by fragile bones that break easily in addition to fractures people with oi often have muscle weakness hearing loss fatigue joint laxity curved bones scoliosis and short stature the majority of cases of oi possibly   are caused by a dominant mutation in a gene coding for type i collagen a key component of healthy bone treatment of oi is supportive focusing on minimizing fractures and maximizing mobility but to date there are no treatments that address the underlying bone weakness about acute exacerbations of copd aecopd  an aecopd is characterised by a sudden worsening in the copd patients symptoms of dyspnoea cough and sputum production they last for several days and requiring in a step up of medication and often hospitalisation aecopds occur in the natural course of the disease but are commonly triggered by infections and air pollution but one third do not have an identifiable trigger both airway and systemic inflammation are characteristic drivers of the disease about hypogonadotrophic hypogonadism hh  hh in men is a clinical syndrome that results from inadequate levels of testosterone this can be primary or secondary due to disruption of one of more levels of the hypothalamicpituitarytesticular axis after the age of  the level of testosterone decreases by about  per year in the obese the decrease in testosterone is increased by the high levels of the aromatase enzyme in the fat tissue these are both considered secondary hypogonadism low levels of testosterone have been related to a range of health outcomes including increasing levels of obesity cardiovascular disease hypertension insulin resistance type  diabetes depression and osteoporosis   about woodford investment management  woodford investment management is a fastgrowing asset management company built on a founding philosophy of transparency and simplicity launched in may  the company has more than £bn assets under management and advice further information can be found at httpswoodfordfundscom   enquiries for further information please contact mereo biopharma group ltd denise scotsknight chief executive officer richard bungay chief financial officer  fti consulting public relations adviser to mereo ben atwell simon conway  source mereo biopharma group ltd view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search denise scots knight pollardknight mereo biopharma group ltd lsg lifesciencesgermanycom  the life sciences web portal for germanspeaking europe personscotsknightdeniseformerlymereobiopharmagroupltd9html zum inhalt home about us contact news people products deals organisations » follow us on twitter » get free newsletter top news fda advisory committee recommends novartis� cart therapy morphosys fda approves janssen�s guselkumab for psoriasis basf introduces new insecticide for malaria prevention wilex reports on first halfyear  epigenomics public takeover offer by summit not successful » more news » submit your news   upcoming events biotech ceo summit europe  enniskerrry ireland isppp  philadelphia berlin conference on life sciences  wedbush pacgrow healthcare conference  new york afm biomed conference  krak�w citi�s th annual biotech conference  boston biocentury annual newsmakers in the biotech industry  new york esmo  congress madrid goldman sachs annual biotech symposium  london basel life  embo � miptec msacl  eu salzburg morgan stanley global healthcare conference  new york jp morgan london smallmid cap conference  boaml global healthcare conference  london hupo  dublin th annual world congress » more events » submit your event   bio regions  life sciences clusters » more clusters and regions » submit your cluster or region   business parks  science centres » more business parks » submit your business park   associations » more associations » submit your association   partners » media partners » become a partner   advertisement person › detailsdenise scots knight pollardknight mereo biopharma group ltdscotsknight denise formerly pollardknight mereo biopharma  ceo before managing partner at phase ventures  organisation mereo biopharma group ltd   formermajor organisation phase partners ltd phase ventures product bgs9 mereo biopharma  novartis   product  venture capital       mereo biopharma group ltd 9 press release mereo biopharma announces formal launch of company raises m london mereo biopharma announces formal launch of company raises m c£m and acquires innovative midstage clinical product portfolio from leading pharmaceutical company a new uk company focused on acquiring rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health highly experienced management team blue chip and deeppocketed investors mereo biopharma group ltd �mereo� a recentlyformed speciality biopharmaceutical company announces that it has successfully raised m c £m gross from blue chip institutional investors and simultaneously acquired a portfolio of three innovative clinicalstage development programmes from novartis pharmaceuticals novartis through the shares issued in consideration for the acquisition of products will also hold an equity stake in mereo mereo is a new ukbased company whose mission is to acquire and rapidly develop innovative medicines that have the potential to transform patient quality of life and improve human health mereo intends to optimise the commercial value of programmes by entering into partnering deals at key value inflection points or for selected opportunities commercialising products itself mereo is building a strong pipeline of innovative medicines particularly focused in rare and specialist disease areas through the acquisition of validated midstage development programmes from large biopharmaceutical companies mereo has access to an extensive network of experts with experience across multiple clinical disciplines and has entered into a strategic development partnership with icon a leading global contract research organisation cro for the clinical development of its portfolio key investment highlights for mereo are as follows an innovative product portfolio from novartis mereo�s initial midstage portfolio comprises three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need acquired from novartis each programme has a comprehensive dataset including proof of concept clinical studies mereo�s pipeline comprises the following programmes bps in the orphan disease osteogenesis imperfecta or brittle bone syndrome is a fully human monoclonal antibody which is being developed to improve bone density and thereby reduce fractures in osteogenesis imperfecta oi commonly known as brittle bone syndrome bct9 in acute exacerbations of copd is an orally active p map kinase inhibitor being developed as firstline acute therapy alongside existing treatment and supportive care for acute exacerbations of chronic obstructive pulmonary disease aecopd bgs9 in hypogonadotrophic hypogonadism is a novel orally active aromatase inhibitor being developed as a firstline therapy for the treatment of obese men with hypogonadotrophic hypogonadism hh with the aim of normalising testosterone levels strategic development partnership with icon mereo�s strategic partnership with icon provides a dedicated global team working closely with mereo from preacquisition through to conduct of global clinical studies for its pipeline products the relationship has been structured to enable mereo to expand its product portfolio without the addition of significant internal resources a strong investor base mereo has secured m c £m gross from uk institutional investors woodford investment management and invesco perpetual in addition novartis through the shares issued in consideration for the acquisition of products will hold an equity stake in mereo and intends to make a cash investment in mereo in future financings a highly experienced management team the team is led by dr denise scotsknight pollardknight as chief executive officer formerly managing partner of the healthcarefocused venture capital investor phase partners and dr peter fellner as chairman who has a wide range of experience in biotechnology and pharma companies mereo�s management team is highly experienced in identifying and selecting new product opportunities managing clinical development pipelines capital raising and structuring in and outlicensing transactions commenting on today�s announcement dr denise scotsknight ceo of mereo said �we believe that by acquiring quality assets from novartis and securing substantial financing we have put in place the building blocks to create a successful specialty biopharmaceutical company through the experience and connections of the team and board we are delighted to have been able to work with a visionary global leader in novartis pharmaceuticals in building a new model to help optimise the development of pharmaceutical pipelines we believe the exceptional experience and track record of the mereo team and board will enable us to rapidly build a globally competitive business� commenting on today�s announcement dr peter fellner chairman of mereo said �we believe the substantial fundraising underpinning the launch of mereo is a strong endorsement from the investment community of our vision to create a ukbased biopharmaceutical leader this reflects both the extensive experience of the management team and board as well as the extremely high quality of programmes acquired from novartis which form the initial portfolio of mereo� wg partners llp acted as advisor to mereo biopharma in connection with this transaction enquiries for further information please contact mereo biopharma group ltd denise scotsknight chief executive officer richard bungay chief financial officer    fti consulting public relations adviser to mereo ben atwell simon conway        record changed 9 advertisement more documents for denise scots knight pollardknight  mereo biopharma group ltd 9 press release mereo biopharma announces formal launch of company raises m london  nabriva therapeutics ag 9 press release nabriva therapeutics strengthens board and management team charles rowland joins supervisory board � dr steven gelone appointed chief development officer vienna  philadelphia pa to subscribe to our free monthly newsletter for the life sciences in germanspeaking europe de at  ch please send an email to infoiitode and simply fill the subject line with the word �lsg newsletter� to get even more information please take a look at our gs professional services offering and read the genesensor product flyer pdf file please visit also our web portals for the european life sciences and the worldwide mass spectrometry industry at lifescienceseuropecom european life sciences and massspeccapitalcom worldwide mass spectrometry please visit also our web portals for the life sciences in germanspeaking europe de at  ch and the worldwide mass spectrometry industry at lifesciencesgermanycom life sciences in germanspeaking europe and massspeccapitalcom worldwide mass spectrometry advertisement » top advertisements � imprint    � contact    the use of this website requires to accept the disclaimer     a project of iito business intelligence   made in germany denise pollardknights involvement in venture capital via idenix pharmaceuticals inc oncomed pharmaceuticals inc cerimon pharmaceuticals inc want to see morewant to find out who got funded and who’s funding the next big thing in real time all across the world tailored to your specific areas of focus deals per dayget access to the most exhaustive worldwide funding watch on the webcomprehensive funding informationknow about who invested in a company which sites covered the event the funding history etcexclusive insightsview original analytics such as most dynamic industries most active investors and morestay awareget emailed when deals critical to your business happen filter by region industry and topics of interestas seen onhave a loginsign inregister nowits freeuse your social accountor fill in the quick formregister nowpromise we wont spamsign invia your social accountvia your existing wgf accountremember meregister its freeforgot your passwordsign inforgot your passwordenter your email and we will send you your new passwordreset passwordthe worlds largest funding basepeoplepollardknightdenisesectionpeoplesubsectiondetailid search deals by company name industry location investors search denisepollardknightget alertedif denise pollardknight gets fundeddenise pollardknightidenix pharmaceuticals inc  directoroncomed pharmaceuticals inc  directorcerimon pharmaceuticals inc  directordeals involving denise pollardknight raised with idenix pharmaceuticals inc on january  raised with idenix pharmaceuticals inc on august  raised with idenix pharmaceuticals inc on february  raised with idenix pharmaceuticals inc on april 999 raised with oncomed pharmaceuticals inc on december  raised with oncomed pharmaceuticals inc on july  raised with cerimon pharmaceuticals inc on april  raised with cerimon pharmaceuticals inc on september 9please note that all data is automatically extracted and errors can occurthe whogotfunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and completesome of the profile information was collected using the crunchbase api for more details on the profile please check denise pollardknigh on crunchbaseinaccurate data help us improve whogotfunded post a comment denise scots knight pollardknight mereo biopharma group ltd lse lifescienceseuropecom  the european life sciences web portal personscotsknightdeniseformerlymereobiopharmagroupltd9html zum inhalt home about us contact news people products deals organisations » follow us on twitter » get free newsletter top news emergent biosolutions acquires acam business from sanofi ali mortazavi appointed as board chairman of ultromics ltd tataa biocenter  btu twotailed pcr for microrna analysis g therapeutics appoints andrew witty to board of directors fda advisory committee recommends novartis� cart therapy » more news » submit your news   upcoming events berlin conference on life sciences  citi�s th annual biotech conference  boston basel life  embo � miptec msacl  eu salzburg morgan stanley global healthcare conference  new york boaml global healthcare conference  london hupo  dublin th annual world congress smash  nmr conference baveno italy european biotech week  biopharm america  boston sachs annual biotech in europe forum  basel asebio investor day  barcelona european business development conference  heidelberg ebdc  worldlab  durban cphi worldwide  frankfurt » more events » submit your event   bio regions  life sciences clusters biopro badenw�rttemberg gmbh flandersbio vzw scanbalt network scanbalt fmba biosaxony e v germany trade and invest � gesellschaft f�r au�enwirtschaft und standortmarketing mbh medicon valley alliance mva life science austria lisa service unit of austria wirtschaftsservice gmbh one nucleus mediwales ci cluster cluster f�r individualisierte immunintervention e v » more clusters and regions » submit your cluster or region   business parks  science centres izb innovations und gr�nderzentrum biotechnologie martinsried f�rdergesellschaft izb mbh genopole gip genopole technologiepark heidelberg gmbh parc cientific de barcelona bcp barcelona science park foundation campus vienna biocenter association vbc medeon science park oxford science park the leiden bio science park foundation biocity nottingham ltd london bioscience innovation centre lbic » more business parks » submit your business park   associations europabio � the european association of bioindustries bioindustry association bia gb emerging biopharmaceutical enterprises ebe france biotech asebio spanish bioindustry association bio deutschland e v european bioeconomy alliance eba » more associations » submit your association   partners » media partners » become a partner   advertisement person › detailsdenise scots knight pollardknight mereo biopharma group ltdscotsknight denise formerly pollardknight mereo biopharma  ceo before managing partner at phase ventures  organisation mereo biopharma group ltd   formermajor organisation phase partners ltd phase ventures product bgs9 mereo biopharma  novartis   product  venture capital       mereo biopharma group ltd 9 press release mereo biopharma announces formal launch of company raises m london mereo biopharma announces formal launch of company raises m c£m and acquires innovative midstage clinical product portfolio from leading pharmaceutical company a new uk company focused on acquiring rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health highly experienced management team blue chip and deeppocketed investors mereo biopharma group ltd �mereo� a recentlyformed speciality biopharmaceutical company announces that it has successfully raised m c £m gross from blue chip institutional investors and simultaneously acquired a portfolio of three innovative clinicalstage development programmes from novartis pharmaceuticals novartis through the shares issued in consideration for the acquisition of products will also hold an equity stake in mereo mereo is a new ukbased company whose mission is to acquire and rapidly develop innovative medicines that have the potential to transform patient quality of life and improve human health mereo intends to optimise the commercial value of programmes by entering into partnering deals at key value inflection points or for selected opportunities commercialising products itself mereo is building a strong pipeline of innovative medicines particularly focused in rare and specialist disease areas through the acquisition of validated midstage development programmes from large biopharmaceutical companies mereo has access to an extensive network of experts with experience across multiple clinical disciplines and has entered into a strategic development partnership with icon a leading global contract research organisation cro for the clinical development of its portfolio key investment highlights for mereo are as follows an innovative product portfolio from novartis mereo�s initial midstage portfolio comprises three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need acquired from novartis each programme has a comprehensive dataset including proof of concept clinical studies mereo�s pipeline comprises the following programmes bps in the orphan disease osteogenesis imperfecta or brittle bone syndrome is a fully human monoclonal antibody which is being developed to improve bone density and thereby reduce fractures in osteogenesis imperfecta oi commonly known as brittle bone syndrome bct9 in acute exacerbations of copd is an orally active p map kinase inhibitor being developed as firstline acute therapy alongside existing treatment and supportive care for acute exacerbations of chronic obstructive pulmonary disease aecopd bgs9 in hypogonadotrophic hypogonadism is a novel orally active aromatase inhibitor being developed as a firstline therapy for the treatment of obese men with hypogonadotrophic hypogonadism hh with the aim of normalising testosterone levels strategic development partnership with icon mereo�s strategic partnership with icon provides a dedicated global team working closely with mereo from preacquisition through to conduct of global clinical studies for its pipeline products the relationship has been structured to enable mereo to expand its product portfolio without the addition of significant internal resources a strong investor base mereo has secured m c £m gross from uk institutional investors woodford investment management and invesco perpetual in addition novartis through the shares issued in consideration for the acquisition of products will hold an equity stake in mereo and intends to make a cash investment in mereo in future financings a highly experienced management team the team is led by dr denise scotsknight pollardknight as chief executive officer formerly managing partner of the healthcarefocused venture capital investor phase partners and dr peter fellner as chairman who has a wide range of experience in biotechnology and pharma companies mereo�s management team is highly experienced in identifying and selecting new product opportunities managing clinical development pipelines capital raising and structuring in and outlicensing transactions commenting on today�s announcement dr denise scotsknight ceo of mereo said �we believe that by acquiring quality assets from novartis and securing substantial financing we have put in place the building blocks to create a successful specialty biopharmaceutical company through the experience and connections of the team and board we are delighted to have been able to work with a visionary global leader in novartis pharmaceuticals in building a new model to help optimise the development of pharmaceutical pipelines we believe the exceptional experience and track record of the mereo team and board will enable us to rapidly build a globally competitive business� commenting on today�s announcement dr peter fellner chairman of mereo said �we believe the substantial fundraising underpinning the launch of mereo is a strong endorsement from the investment community of our vision to create a ukbased biopharmaceutical leader this reflects both the extensive experience of the management team and board as well as the extremely high quality of programmes acquired from novartis which form the initial portfolio of mereo� wg partners llp acted as advisor to mereo biopharma in connection with this transaction enquiries for further information please contact mereo biopharma group ltd denise scotsknight chief executive officer richard bungay chief financial officer    fti consulting public relations adviser to mereo ben atwell simon conway        record changed 9 advertisement more documents for denise scots knight pollardknight  mereo biopharma group ltd 9 press release mereo biopharma announces formal launch of company raises m london  nabriva therapeutics ag 9 press release nabriva therapeutics strengthens board and management team charles rowland joins supervisory board � dr steven gelone appointed chief development officer vienna  philadelphia pa to subscribe to our free monthly newsletter for the european life sciences please send an email to infoiitode and simply fill the subject line with the word �lse newsletter� to get even more information please take a look at our gs professional services offering and read the genesensor product flyer pdf file advertisement » top advertisements � imprint    � contact    the use of this website requires to accept the disclaimer     a project of iito business intelligence   made in germany denise pollardknight   decypha sign in  welcome guest regions gcc  levant  mena  north africa gcc bahrain  kuwait  oman  qatar  saudi arabia  united arab emirates levant iraq  jordan  lebanon  palestine north africa egypt  libya  morocco  tunisia others iran  turkey  united kingdom  united states advanced search news markets companies research funds fixed income money markets commodities fx economics analysis more sign in membership customize your decypha logout welcome decypha alerts home people profiles people profile denise pollardknight profile full name denise pollardknight country biography dr pollardknight has served as managing partner of phase  ventures since december  phase  ventures manages funds on behalf of nomura european designations date designation entity entity description country  idenix pharmaceuticals inc   check all the individuals in check the list request a trial title select mr mrs ms miss dr prof first name last name job title select asset managers corporate banks investment managers wealth managers consultants  advisors legal practioners academics hedge funds private equity analysts traders equity research analysts phone company email country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe comments required fields   submit already registered login attempt was not successful please try again username email password enter characters   login forget your password by job title asset managers  corporate banks  investment managers  wealth managers  consultants  advisors  legal practitioners  academics  hedge funds  private equity analysts  traders  equity research analysts by scope equity  fixed income  funds  excel  analytical tools  markets  prices  money market  news  industry  ipos  mergers  acquisitions  commodities  economics covered countries and exchanges add your company   add yourself   terms and conditions   privacy policy   about directfn copyright  directfn all rights reserved data not available login login attempt was not successful please try again username email password enter characters forget your password back to top support  feedback ask for free trial request a trial title mr mrs ms miss dr prof first name last name email phone promo code country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe company job title select academics asset managers consultants  advisors corporate banks equity research analysts hedge funds investment managers legal practioners private equity analysts traders wealth managers comments required fields   submit contact us hello please use the below form for product support  feedback name   email  phone number   preferred contact method  email phone technical support x 9    slhopsdirectfnnet your account manager is   get a decypha membership to view this content get a decypha membership get the membership of decypha premium package to access more exciting features including advanced analytical tools and the pro  package pro  is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire all you need to access these valuable features is to click on the get a membership button and submit your details to our sales team upgrade your membership account is not entitled to view this information please contact your account manager to upgrade your membership email  supportdecyphacom register to view this content decypha free registration register free with decypha and get access to realtime price information and many other features including technical scanner fundamental screener etc just click the registration button submit your details and get registered for free denise pollardknight  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors denise pollardknight check out list of companies and businesses related to denise pollardknight find out denise pollardknight address and contact details view other people related to denise pollardknight  coworkers colleagues companions etc address co idenix pharmaceuticals inc  hampshire street cambridge 9 ma companies related to denise pollardknight cikcompany namepositioncompany address99idenix pharmaceuticals incdirector  bent street cambridge oncomed pharmaceuticals incdirector  chesapeake drive redwood city 9albireo pharma incdirector  post office square suite  south boston 9 denise pollardknight on the web persons related to denise pollardknight  idenix pharmaceuticals incnamepositioncityrosenberg anthonycambridgedavid arkowitzchief financial officer cambridgebio ventures llp babbostonbio ventures nv babbostoncharlene barshefskydirector cambridgebaupost group llcma owner bostonbaupost group llcma owner bostonbaupost value partners lp ivbostonbb bioventures l p owner bostondaniella beckmansvp cfo and treasurer cambridgedaniella beckmansvp cfo and treasurer cambridgebrookside capital investors ii lpbostonbrookside capital investors ii lpbostonbrookside capital management llcbostonbrookside capital trading fund lpbostonbrookside capital trading fund lpbostonnathaniel brownchief medical officer cambridgecramb charlescambridgeandrea corcoranexec vp legal and admin cambridgeandrea corcoranexec vp legal and admin cambridgecharles w cramb jrdirector cambridgebeckman daniellacambridgestandring davidcambridgepollardknight denisecambridgemayers douglascambridgejacques dumasevp chief scientific officer cambridgethomas ebelingcambridgejames egansr vp business development cambridgeluke evninbostonpaul fanningsvp human resources cambridgepaul fanningsvp human resources cambridgeansbert gadickedirector bostonbrian goffcambridgewayne t hockmeyerdirector cambridgewayne t hockmeyerdirector cambridgethomas r hodgsondirector cambridgethomas r hodgsondirector cambridgetamar d howsondirector cambridgetamar d howsondirector cambridgeseth a klarmanbostonseth a klarmanbostonsusan koppysr vp business and corp dev cambridgeguy macdonaldexecutive vp operations cambridgestahl mariacambridgedouglas l mayersevp and chief medical officer cambridgedouglas l mayersevp and chief medical officer cambridgempm asset management investors 99 llcmabostonmpm asset management llcbostonmpm bio ventures i llcbostonmpm bio ventures i lpbostonmpm bio ventures parallel fund l pbostonag novartisch baselag novartis baselag novartisbaselag novartis owner ag novartis owner ag novartis owner basel switzerlandag novartis owner baselag novartis owner baselpharma ag novartisch baselpharma ag novartis owner baselpharma ag novartispharma ag novartispharma ag novartisbasel switzerlandpharma ag novartisbaselpharma ag novartisbaselpharma ag novartisbaselfanning paulcambridgenorman c md paysondirector cambridgerobert pelzerbostondenise pollardknightdirector cambridgedenise pollardknightdirector cambridgesteven projancambridgeemmanuel puginiercambridgeronald c renaud jrpresident  ceo cambridgeronald c renaud jrpresident  ceo cambridgepelzer robertcambridgerenaud jr ronaldcambridgeanthony rosenbergcambridgecharles a rowland jrdirector cambridgesak corpbostondavid shlaescambridgejeanpierre sommadossipresident ceo chairman cambridgejeanpierre sommadossipresident ceo chairman cambridgemaria d stahlsvp  general counsel cambridgemaria d stahlsvp  general counsel cambridgedavid standringevp  chief scientific officer cambridgemichael steinmetzbostonhowson tamarcambridgepamela thomasgrahamdirector cambridgehodgson thomascambridgehockmeyer waynecambridgejohn weidenbruchex vp gen counsel and secr cambridgemichael s wyzgadirector cambrdgemichael s wyzgadirector cambrdgepersons related to denise pollardknight  oncomed pharmaceuticals incnamepositioncityhager aliciaredwood citygurney austinredwood cityjames w broderickdirector redwood citypakianathan deeparedwood citypollardknight deniseredwood cityjakob dupontsvp  chief medical officer redwood cityirwin federmanmenlo parkwinston s fumenlo parkplc glaxosmithkline owner brentford middlesexterry p goulddirector redwood cityaustin gurneysee remarks redwood cityalicia j hagersvp  general counsel redwood citypaul j hastingschairman  ceo paul j hastingschairman  ceo redwood citytimothy hoeysvp cancer biology  cocso redwood citylasersohn jackredwood citydupont jakobredwood citybroderick jamesredwood citywoody jimredwood citylewicki johnredwood cityroot jonathanredwood cityperry a karsendirector rockvillesteven m krauszmenlo parklasky larryredwood cityjack w lasersohndirector summitjack w lasersohndirector redwood citylaurence laskydirector redwood citypatrick f latterellsan franciscopatrick f latterellsan franciscojohn a lewickievp research  development redwood citydavid e liddlemenlo parklvp gp i llc owner san franciscolvp gp ii llcsan franciscolvp gp iii llcsan franciscolvp iii associates lpsan franciscolvp iii partners lpsan franciscolvp life science ventures i lpsan franciscolvp life science ventures ii lpsan franciscolvp life science ventures iii lpsan franciscolvpmc llcsan franciscolvpmc llcsan franciscowyzga michaelredwood citymorgenthaler management partners vii llcmenlo parkmorgenthaler partners vii lp owner menlo parkdeepika pakianathandirector palo altodeepika pakianathandirector redwood citydeepika pakianathandirector menlo parkdeepika pakianathandirector menlo parksunil patelsee remarks mountain viewsunil patelsee remarks redwood cityhastings paulredwood citydenise pollardknightdirector cambridgedenise pollardknightdirector redwood citymanagement group viii l l c presidio owner menlo parkjonathan d rootdirector menlo parkjonathan d rootdirector redwood citychristopher j rustmenlo parkpatel sunilredwood citycasey m tanseymenlo parkgould terryredwood cityhoey timothyredwood cityus venture partners viii l pmenlo parkusvp entrepreneur partners viii a l pmenlo parkusvp entrepreneur partners viii b l pmenlo parkusvp viii affiliates fund l pmenlo parkvertical group lp owner summitwilliam d waddillsvp  chief financial officer redwood citywaddill williamredwood cityrick e winninghamdirector south san franciscojames n woodydirector redwood citymichael s wyzgadirector michael s wyzgadirector redwood cityphilip m youngmenlo parkpersons related to denise pollardknight  albireo pharma incnamepositioncitykrasner alandanburyab astrazenecasodertaljeplc astrazenecalondonginsberg barrydanburypaul s baviergeneral counsel danburypaul s baviergeneral counsel danburypaul s baviergeneral counselcorp sec danburypaul s baviergeneral counsel danburypaul s baviergeneral counselcorp sec danburydavid bondermanpereira briandanburyjulia r browndirector san diegojulia r browndirector danburymartha j carterchief regulatory officer morristowndonald m jr caseydirector danburyalbert chadirector danburyalbert chadirector danburydavid chiswelldirector bostonronald harold wilfred cooperpresident and ceo cambridgejames g coulterforth worthlorber danieldanburyscoon daveydanburyerrol b desouzaceo errol b desouzaceo danburyerrol b desouzaceo danburyerrol b desouzaceo danburyerrol b desouzaceo danburyerrol b desouzaceo and president danburyerrol b desouzaceo danburysteiner erikdanburyde souza erroldanburyrobert feldsteinvice president danburyrobert feldsteinvice president patents ip danburygary g gemignanichief financial officer danburymichel gerarddanburybarry h ginsbergdirector danburybarry h ginsbergdirector danburygreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners i lp owner greenwichgreat point partners llcgreenwichmichael gutchdirector bostonlieberman iradanburysamuel d isalynew yorkbrown juliedanburyalan seth krasnerchief medical officer danburyalan seth krasnerchief medical officer danburyalan seth krasnerchief medical officer danburyalan seth krasnerchief medical officer danburydavid kroindirector danburydavid kroindirector danburydavid kroindirector danburyira liebermandirector danburyira liebermandirector danburyira liebermandirector danburydaniel lorberdirector danburydaniel lorberdirector danburyjan mattssonchief operating officer bostonalastair mckinnonedinburghgerard j michelcfo vp of corp and devtreas danburygerard j michelcfo vp of corp dev and treas danburygerard j michelcfo vp of corp and devtreas danburyarlene morrisdirector san diegoorbimed advisors llc owner new yorkorbimed advisors llcdirector new yorkbavier pauldanburybrian jg pereiradirector danburybrian jg pereiradirector danburybrian jg pereiradirector danburyandreas pfutznerchief medical officer danburyandreas pfutznerchief medical officer in europ danburyphase partners ltdedinburghphase ventures iii general partner ltdedinburghphase ventures iii gp lpedinburghphase ventures iii lpedinburghroderike pohldanburyroderike pohlvp research danburyroderike pohlvp research danburyroderike pohlvice president research danburydenise pollardknightdirector cambridgeheather prestondirector fort worthf scott redingchief financial officer danburycharles a sandersdirector danburycharles a sandersdirector danburycharles a sandersdirector danburycharles a sanderschapel hilldavey scoondirector bedforddavey scoondirector danburypaul j sekhridanburycharles sermonedinburghthomas a sheacfo and treasurer bostonparesh sonichief medical officer mysticerik steinervice president operations danburyerik steinervicepresident operations danburyerik steinervicepresident operations danburyerik steinervicepresident operations danburysolomon steinerpresident  ceo danburysolomon steinerdirector danburysolomon steinerdirector danburysteiner ventures llcmt kiscosteiner ventures llc owner danburytpg group holdings sbs advisors incfort worthj arthur urciuolidirector danburyj arthur urciuolidirector danburyvivo ventures v llc owner palo altor timmis warecorp secy and general counsel danburyr timmis warecorp secy and general counsel danburyscott weismandirector danburyscott weismandirector danburysamuel p wertheimerdirector new yorksamuel p wertheimerdirector danburysamuel p wertheimerdirector danburypeter a zornchief corp officer gc  sec winstonsalem potentially same personnamecitycountrypollardknight denisesouth san franciscocapollardknight denisecambridgemapollardknight deniseredwood cityca microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext9 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft background checks and public records search  truthfinder call toll free  99 public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip whats your age submit i dont know skip background checks and public records search  truthfinder call toll free  99 public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free  99 public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free  99 public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free  99 public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip